Jurgen Rohr and Axel Zeeck
Institut fur Organische Chemie, Universitat Gottingen, Tammannstrasse 2, D-3400 Gottingen, W. Germany (Received for publication April 5, 1990) Thestructure-activity relationships of the anthracycline-related antibiotics of the tetracenomycin C/elloramycin-type were investigated by derivatization of elloramycin (1) and elloramycinone (2) . During hydrolysis experiments a unique transglycosylation reaction was discovered, converting elloramycin (1) into isoelloramycin (10) by treatment with anhydrous trifluoroacetic acid. Following the proposed structure-activity relationship concept, 8-O-methylelloramycinone (14) was synthesized from elloramycinone (2) , and was shown to be the most active derivative according to the proliferation inhibition assay against murine L1210 leukemia cells.
The elloramycins A (1) to F!~3) and tetracenomycins C (13)4~6) and X (14)7), produced by Streptomycesand Nocardia species, form a small group of antibiotics, which is unique relative to their molecular structure as well as biological activity (mainly against Gram-positive bacteria of the genus Streptomyces, but also as antitumor antibiotics).
Tetracenomycin C (13) was the first example of this discrete group, discovered in 19794>5), then again in 19848) and, as its 12a-O-methyl ether (tetracenomycin X, 14) in 19897). Because of the linear tetracyclic ring system and its obvious biogenetic origin from a decaketide, the tetracenomycin C-type antibiotics are related to the tetracyclines and the anthracyclines9). But in contrast to these antibiotics, which have several group members, tetracenomycin C has only a few relatives. Unique in the commonstructure of these antibiotics is the 2,3-dihydro-l ,4-anthraquinone chromophore; the partially saturated ring A, which has an o,/?-unsaturated keto group as structural element, resembles some anthracycline antibiotics, e.g., aranciamycin (18)10 ll), the steffimycins (19)12 l3) and akrobomycinl4).
Biosynthetic investigations on tetracenomycin X (14)7) focussing especially on oxidation processes proved the tetracyclic ring frame to derive from 10 acetate units, leaving only the question whether some red congeners of tetracenomycin C, namely tetracenomycins A2 (5), B3 (6) and D3 (7, the latter two were isolated from a blocked mutant of the elloramycin-producer Streptomyces olivaceus) are intermediates or shunt products of the biosynthetic pathway to 1, 13 or 1415~17). The only relatives of the tetracenomycins C and Xhaving a sugar moiety as a structural element are the elloramycins1'^, which are phenolic bonded dior trimethylrhamnosides. The main compound, elloramycin A (1) is biologically active against murine L1210leukemia cells, but weaker than its sugarless relative 13. This was unexpected, since most of the anthracyclines showa muchhigher biological activity than their aglycones. Somechemically interesting hydrolysis phenomenaand the little knownstructure-activity relationships of this unique group of antibiotics were also reasons of our investigations.
Hydrolysis and Transglycosylation As starting material for semisynthetic studies and different biological tests, elloramycinone (2) had to be produced in good yields. The methanolysis of 1 with methanolic sulfuric acid gave only 37%of 2. The reason for the low yield is an isomerization of 2 to isoelloramycinone (9) via 3-demethylelloramycinone (8) , SEPT. 1990 Scheme 1. caused by the vinylogue ester function in ring A (Scheme 1), and by shunt products, of which anhydroelloramycin (3) could be obtained and characterized as the main compound amongother unidentified red dyes. The aromatization of ring A by which the yellow 2,3-dihydro-l ,4-anthraquinone chromophore of 1 is changed into a red naphthacenequinone happens partially before the scission of the glycosidic bond. The poor solubility of 3 in methanol protects it from further degradation. The use of hydrochloric acid instead of sulfuric acid increased the amount of red dyes, among which the 7-chloroanhydroelloramycinonic acid (4) is an unusual product, whose chlorination mechanismis not clear. Systematic variation of the hydrolysis conditions showedtrifluoroacetic acid to be the optimal reagent. In the presence of water, elloramycinone (2) was the only product1}, while under dry conditions, isoelloramycin (10) with the sugar rearranged from position 8 to position 4 was the main product. The structure of 10 was established by the NMRdata, the UVspectrum under basic conditions showing a free hydroxy group at C-8 as in 2, and the El mass spectrum (Scheme 2)1}. The molecular ion at m\z 660 and the retro-diene cleavage indicates that the sugar is connected to the smaller ring Afragment. The rearrangement from 1 to 10 was of further interest considering whether the reaction is an intra-or intermolecular transglycosylation and the possibility of establishing that reaction as a general glycosylation method.
Whenelloramycin (1) was treated with dry trifluoroacetic acid in the presence of tetracenomycin C (13), which resembles elloramycinone (2), 25 % 4-O-permethylrhamnosyl-tetracenomycin C (ll) could be isolated from the reaction mixture besides 27%isoelloramycin (10) . This result proves the favoured intermolecular two-step process. The liberated sugar moiety (12) has a higher affinity to 4-OHof elloramycinone (2) or tetracenomycin C (13) within a glycosylation reaction than to 8-OHof 2 (back reaction). We assume a mechanism with l-O-trifluoroacetyl-2,3,4-tri-O-methyl-^-L-rhamnose (12) To prove this hypothesis, per-O-methyl-L-rhamnose was synthesized, demethylated in the 1-position, functionalized as 1-0-trifluoroacetate (12, a-fi, 1 : 1) and added as anomeric mixture to elloramycinone (2) in dry trifluoroacetic acid. The obtained product mixture of isoelloramycin (10) and its yS-isomer verifies the proposed mechanism. With 12 as a reagent, it was also possible to glycosylate tetracenomycin C (13) and aranciamycinone (16) as well, which leads to ll, its £-isomer and to S'^'-di-O-methylaranciamycin (17), respectively. In the case of 16 only the a-glycosidic rhamnoside 17 was detectable.
-O-Methylelloramycinone
Tetracenomycin C (13) is assumed to intercalate with DNA,requiring a flat structural moiety to move THE JOURNAL OF ANTIBIOTICS SEPT. 1990 Scheme 4. in between the base pairs. Rings B, C and D of 13 are in agreement with this condition, while ring A probably blocks the intercalation at a certain point. Elloramycin (1) has large substituents on both sides of its chromophore2), which decreases its effectiveness of intercalation. Thus isoelloramycin (10) with the sugar moiety on the "right" side and also elloramycinone (2) were expected to have a better antitumor activity than 1. But the IC50 value in the proliferation assay (Table 1) shows a weaker cytotoxic activity of 10 by comparison with 1, and 2 shows only a slightly better activity than 1, but is less active than tetracenomycin C (13). Since 2 and 13 are structural isomers and differ only within the position of the methoxy group (C-8 or C-12a), it was necessary to find out which structural differences are responsible for the different biological activity. Three semisynthetic approachesto establish these structure-activity relationships were theoretically possible: (i) A selective ether cleavage of 12a-OCH3 of elloramycinone (2), (ii) a selective methylation of 12a-OH of tetracenomycin C (13) or (iii) a selective methylation of the phenolic 8-OH position of elloramycinone (2) . The ether cleavage of 12a-OCH3in 2 is chemically difficult to realize, and experiments with different reagents (BF3, A1C13, (CH3)3SiI) showed lack of selectivity.
Methylation experiments with tetracenomycin C (13) resulted in the desired molecule, (14, see below), but in very low yields, due to the various inevitable multiple methylated products. The third possibility, the methylation of 8-OH of 2, could be established by the following reaction sequence (Scheme 5): Starting from 2, 4-OH and ll-OH were protected as trimethylsilyl ether (20) . After methylation of 8-OHwith diazomethane and deprotection of the trimethylsilyl groups with hydrochloric acid, the goal molecule 14 could be obtained in 85 % overall yield. Experiments starting from 1 using the sugar as protection group, peracetylation, hydrolysis of the sugar, methylation of 8-OHand deprotection of the acetyl groups failed because of the low yielding deprotection of the 1 1-O-acetyl group. Direct methylation of 2 always gave the 8, 1 1-di-O-methylelloramycinone (15). 
Discussion
The experiments on elloramycin ( 1) give additional information about structure-activity relationships of the tetracenomycin C (13) (Table 1) 19), Le. that 8-OH and 12a-OH cause negative interactions with the DNA,thus lowering the anti-cancer activity, and should rather be methylated. The structure and biosynthetic investigations on tetracenomycin X (14) were published during the preparation of this paper, but no biological activities of this newest memberof the tetracenomycin/elloramycin antibiotics were described7).
The sugar rearrangement which has been discovered during the hydrolysis experiments is until now unique. The reason for this rearrangement can be the thermodynamically stronger glycosidic bond between the secondary hydroxy group at C-4 in comparison with the phenolic hydroxy group at C-8. Twopotential general synthetic approaches could follow from this discovery: The activation of a sugar as l-Otrifluoroacetate or the activation of a sugar within a phenolic glycoside in the presence of trifluoroacetic acid. In the latter case the sugar can be transferred by an intermolecular transglycosylation. This method might be advantageous, especially if the accepting secondary alcohol has a a,/3-double bond, usually very difficult to glycosylate. The transglycosylation experiments described in this paper prove this potential and will be the subject of further investigations. (3), red SEPT. 1990 and several other minor unidentified red products. b) With HC1: Using 37% HC1instead ofsulfuric acid gave mostly the same products as above. Instead of 3, 5 mg (4%) of 7-chloroanhydroelloramycinonic acid (4) could be isolated. Isoelloramycin ( 10) Elloramycin (1, 100mg) was dissolved in 10ml anhydrous TFA and stirred in the presence of 4A molecular sieves in a nitrogen atmosphere at 50°C for 30 minutes. The solution was diluted by 100 ml CHC13, the acid was removed by extraction with water (3 x 50ml each). The organic layer was evaporated to dryness. Chromatography on silica gel (column, 20x 2.5 cm, CHCl3-MeOH, 9 : 1) and Sephadex LH-20 (column, 100x 2.5cm, MeOH) yielded 32mg (45%) of elloramycinone (2) and 52mg (52%) of isoelloramycin (10) were stirred in a mixture of 20ml glacial AcOHand 3ml of 3m H2SO4 for 5 minutes at 80°C. The mixture was poured into 100ml ice-water, the products were extracted with 50ml of CHC13,and last traces of the acids were removed by washing the organic layer with 20ml of a saturated aqueous solution of NaHCO3.Chromatography on silica gel 
The sugar from b) (above) was dissolved in 20ml of trifluoroacetic anhydride-pyridine (1 : 1) and stirred for 24 hours at room temperature until no starting material could be detected (TLC, phosphomolybdic acid as staining reagent), residues were removed azeotropically with toluene. Finally, the product was dried 24 hours under reduced pressure to yield 260mg of 12 as a syrup, which was not cleaned further for the glycosylation reactions described below.
Glycosylation with 12
Each aglycone (20mg, eljoramycinone (2), tetracenomycin C (13), aranciamycinone (16)) were dissolved in 5 ml anhydrous TFA (with the presence of 4A molecular sieves) and treated with 60mg of the 3.04 (s, 3.10 (dd, J=9 and 9Hz, 3.39, 3.43, 3.48, 3.51, 3.53, 3.57 (6xs,  (2) in 12 ml pyridine -hexamethyldisilazane (3 : 1) was treated with 5 ml trimethylchlorosilane at 40°C for 1 hour; the stirring was continued for 12 hours at room temperature. It was evaporated to dryness, pyridine was removed azeotropically with toluene. The solid residue was chromatographed on silica gel (column: 30X 5cm, 95 : 5) , to yield 248mg (63%) 20, 45mg 2 could be recovered.
IR ( 4 (2Xq, 71.8 (d, , 88.3 (s, C-12a), 88.9 (s, C-4a), 100.5 (d, C-2), 108.6 (s, C-9), 113.0 (d, C-7), 120.3 (d, C-6), 120.4 and 123.1 (2xs, C-6a and C-lla), 128.5 (s, C-lOa), 
